- Home
- KLRS vs WGRX Comparison
KLRS vs WGRX Comparison
Compare KLRS & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- WGRX
- Stock Information
- Founded
- KLRS 2019
- WGRX 2022
- Country
- KLRS United States
- WGRX United States
- Employees
- KLRS N/A
- WGRX N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- WGRX Other Pharmaceuticals
- Sector
- KLRS Health Care
- WGRX Health Care
- Exchange
- KLRS Nasdaq
- WGRX Nasdaq
- Market Cap
- KLRS 46.0M
- WGRX 43.9M
- IPO Year
- KLRS N/A
- WGRX 2025
- Fundamental
- Price
- KLRS $4.97
- WGRX $0.76
- Analyst Decision
- KLRS Strong Buy
- WGRX
- Analyst Count
- KLRS 2
- WGRX 0
- Target Price
- KLRS $23.00
- WGRX N/A
- AVG Volume (30 Days)
- KLRS 175.7K
- WGRX 41.7M
- Earning Date
- KLRS 11-15-2025
- WGRX 11-19-2025
- Dividend Yield
- KLRS N/A
- WGRX N/A
- EPS Growth
- KLRS N/A
- WGRX N/A
- EPS
- KLRS N/A
- WGRX N/A
- Revenue
- KLRS N/A
- WGRX $36,738,599.00
- Revenue This Year
- KLRS N/A
- WGRX N/A
- Revenue Next Year
- KLRS N/A
- WGRX N/A
- P/E Ratio
- KLRS N/A
- WGRX N/A
- Revenue Growth
- KLRS N/A
- WGRX 82384.51
- 52 Week Low
- KLRS $2.14
- WGRX $0.34
- 52 Week High
- KLRS $24.15
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- KLRS 49.92
- WGRX 48.88
- Support Level
- KLRS $4.70
- WGRX $0.55
- Resistance Level
- KLRS $5.30
- WGRX $0.82
- Average True Range (ATR)
- KLRS 0.41
- WGRX 0.14
- MACD
- KLRS -0.06
- WGRX 0.04
- Stochastic Oscillator
- KLRS 67.48
- WGRX 33.35
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.